[P1–044]: SAFETY OF SOLANEZUMAB IN PHASE 3 STUDIES IN INDIVIDUALS WITH MILD ALZHEIMER's DISEASE DEMENTIA. (1st July 2017) - Carlson, Christopher D.; Anglin, Greg; Case, Michael G.; Crowe, Brenda; Hake, Ann Marie; Khanna, Rashna; Kryzhanovskaya, Ludmila; Perahia, David; Sethuraman, Gopalan; Yaari, Roy; Dowsett, Sherie A.; Siemers, Eric R.